Murali Ramachandran - Insider Non-Derivative Transactions at Kairos Pharma, LTD. (KAPA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 8, 2025, Murali Ramachandran's relationship to Kairos Pharma, LTD. (KAPA) is Officer (VP of Research and Development), and currently has 299,529 shares of COMMON STOCK.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KAPA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Murali Ramachandran - Insider Non-Derivative Transactions of KAPA COMMON STOCK

Murali Ramachandran - Insider Non-Derivative Transactions at KAPA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 9, 2025	Acquisition -- (COMMON STOCK)	152672	0	299529
Jan 2, 2025	Acquisition -- (COMMON STOCK)	14000	0	147057
Nov 26, 2024	P -- (COMMON STOCK)	200	1.59	133057